Mylan’s subsidiary Mylan Pharmaceuticals Inc. has launched Oxycodone
and Aspirin Tablets USP, 4.8355 mg/325 mg, based on an agreement with licensing
partner Coastal Pharmaceuticals. This product is the generic version of Endo Pharmaceuticals'
Percodan Tablets, a treatment for moderate to severe pain.
Oxycodone and Aspirin Tablets had U.S. sales of approximately $6.5 million
for the 12 months ending Dec. 31, 2010, according to IMS Health.